1-10 of 10
Munir Shahjahan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

Mohamed L. Sorror, Sergio Giralt, Brenda M. Sandmaier, Marcos De Lima, Munir Shahjahan, David G. Maloney, H. Joachim Deeg, Frederick R. Appelbaum, Barry Storer, Rainer Storb
Journal: Blood
Blood (2007) 110 (13): 4606–4613.
https://doi.org/10.1182/blood-2007-06-096966
Published: 2007
Journal Articles

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Betul Oran, MD, Sergio Giralt, MD, Munir Shahjahan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Shubhra Ghosh, MD, Ernesto de Meis, MD, Michele Donato, MD, Touch Ativivas, MD, Antonio Carrasco-Yalan, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2005) 106 (11): 2019.
https://doi.org/10.1182/blood.V106.11.2019.2019
Published: 2005
Journal Articles

Treatment of Graft Failure with Fludarabine (Flu), Antithymocyte Globulin (ATG) and a Second Allogeneic Stem Cell Transplantation (SCT).

Elias J. Jabbour, MD, Munir Shahjahan, MD, Gabriela Rondon, MD, Paolo Anderlini, MD, Sergio Giralt, MD, Daniel R. Couriel, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2005) 106 (11): 2734.
https://doi.org/10.1182/blood.V106.11.2734.2734
Published: 2005
Journal Articles

IV Busulfan (Bu) with Fludarabine (Flu) or Cyclophosphamide (Cy) - Comparing Ablative Conditioning Regimens for Allogeneic Transplantation in AML/MDS.

Marcos de Lima, Daniel Couriel, Munir Shahjahan, Jorge Alamo, Peter F. Thall, James Russell, Paolo Anderlini, Sergio Giralt, Elizabeth J. Shpall, Roy B. Jones, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2004) 104 (11): 97.
https://doi.org/10.1182/blood.V104.11.97.97
Published: 2004
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients Aged 65 Years or Older with AML and MDS.

Marcos de Lima, Munir Shahjahan, Jorge Alamo, Patricia Williams, Brigitte von Wolff, Daniel Couriel, Issa Khouri, Gabriela Rondon, Brandy Wheeler, Elihu Estey, Naoto Ueno, Partow Kebriaei, Richard Champlin, Sergio Giralt
Journal: Blood
Blood (2004) 104 (11): 2301.
https://doi.org/10.1182/blood.V104.11.2301.2301
Published: 2004
Journal Articles

Age Does Not Influence Long-Term Quality of Life (QOL) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for AML/MDS.

Munir Shahjahan, Jorge Alamo, Sergio Giralt, Michelle Detry, Mark Munsell, Elihu Estey, Richard Champlin, Marcos de Lima
Journal: Blood
Blood (2004) 104 (11): 2193.
https://doi.org/10.1182/blood.V104.11.2193.2193
Published: 2004
Journal Articles

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Marcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, Munir Shahjahan, Naoto Ueno, Cindy Ippoliti, Borje S. Andersson, James Gajewski, Daniel Couriel, Jorge Cortes, Michele Donato, Joyce Neumann, Richard Champlin, Sergio Giralt
Journal: Blood
Blood (2004) 104 (3): 865–872.
https://doi.org/10.1182/blood-2003-11-3750
Published: 2004
Journal Articles

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

Clinical Trials & Observations
Marcos de Lima, Daniel Couriel, Peter F. Thall, Xuemei Wang, Timothy Madden, Roy Jones, Elizabeth J. Shpall, Munir Shahjahan, Betty Pierre, Sergio Giralt, Martin Korbling, James A. Russell, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2004) 104 (3): 857–864.
https://doi.org/10.1182/blood-2004-02-0414
Published: 2004
Journal Articles

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters

Clinical Trials & Observations
Maha El-Zimaity, Rima Saliba, Kawah Chan, Munir Shahjahan, Antonio Carrasco, Ola Khorshid, Humberto Caldera, Daniel Couriel, Sergio Giralt, Issa Khouri, Cindy Ippoliti, Richard Champlin, Marcos de Lima
Journal: Blood
Blood (2004) 103 (12): 4674–4680.
https://doi.org/10.1182/blood-2003-08-2815
Published: 2004
Journal Articles

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

Clinical Trials & Observations
Raymond Wong, Sergio A. Giralt, Thomas Martin, Daniel R. Couriel, Athanasios Anagnostopoulos, Chitra Hosing, Borje S. Andersson, Pedro Cano, Munir Shahjahan, Cindy Ippoliti, Elihu H. Estey, John McMannis, James L. Gajewski, Richard E. Champlin, Marcos de Lima
Journal: Blood
Blood (2003) 102 (8): 3052–3059.
https://doi.org/10.1182/blood-2003-03-0855
Published: 2003